Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. NKE
2. TSLA
3. MU
4. SPY
5. META
6. ABVX
7. NVDA
8. BE
9. SPCX
10. STZ

Go back to Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
Johnson & Johnson (NYSE: JNJ) Delayed: 253.98 --0.01 (-0%)
Previous Close $253.97    52 Week High $126.07 
Open $253.25    52 Week Low $94.28 
Day High $254.20    P/E 52.80 
Day Low $251.08    EPS $4.81 
Volume 6,515,891